Positron emission tomography in internal medicine

FDG-PET is now an established diagnostic tool in oncology. Fluorodeoxyglucose is not a specific tracer for malignant lesions but rather for elevated glucose metabolism, present not only in cancer but also in inflammatory and infectious lesions. FDG-PET has thus been suggested for diagnosis of fevers...

Full description

Saved in:
Bibliographic Details
Published in:La Presse médicale (1983) 2008-03, Vol.37 (3 Pt 2), p.460-469
Main Authors: Bonardel, Gérald, Lecoules, Stéphane, Mantzarides, Marina, Carmoi, Thierry, Gontier, Eric, Blade, Jean-Sébastien, Soret, Marine, Foehrenbach, Hervé, Algayres, Jean-Pierre
Format: Article
Language:fre
Subjects:
Humans
Infection - diagnostic imaging
Internal Medicine - methods
Positron-Emission Tomography
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:FDG-PET is now an established diagnostic tool in oncology. Fluorodeoxyglucose is not a specific tracer for malignant lesions but rather for elevated glucose metabolism, present not only in cancer but also in inflammatory and infectious lesions. FDG-PET has thus been suggested for diagnosis of fevers of unknown origin, deep bone or visceral infectious foci, inflammatory vasculitis or sarcoidosis and unknown primary tumors, all frequent situation in internal medicine. The main characteristics of FDG-PET are its ability to rule out focal inflammation or infection with a high degree of certainty when the examination is negative because of its good negative predictive value and its usefulness as an early marker of therapeutic response, compared with anatomy-based or conventional scintigraphic imaging. Large-scale prospective studies are necessary, however, before FDG-PET is integrated into routine clinical use. It should be compared with different techniques already validated (biology, radiology, conventional scintigraphic imaging) and its cost-effectiveness should be evaluated.
ISSN:2213-0276
DOI:10.1016/j.lpm.2007.04.030